Development and validation of a next-generation sequencing-based multigene assay to predict the prognosis of estrogen receptor-positive, HER2-negative breast cancer
- Clin. Cancer Res., Published first October 7, 2020 | https://doi.org/10.1158/1078-0432.CCR-20-2107